- Home
- RCKT vs TOI Comparison
RCKT vs TOI Comparison
Compare RCKT & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- TOI
- Stock Information
- Founded
- RCKT 1999
- TOI 2007
- Country
- RCKT United States
- TOI United States
- Employees
- RCKT N/A
- TOI N/A
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- TOI Medical/Nursing Services
- Sector
- RCKT Health Care
- TOI Health Care
- Exchange
- RCKT Nasdaq
- TOI Nasdaq
- Market Cap
- RCKT 326.4M
- TOI 266.8M
- IPO Year
- RCKT N/A
- TOI N/A
- Fundamental
- Price
- RCKT $2.48
- TOI $2.07
- Analyst Decision
- RCKT Buy
- TOI
- Analyst Count
- RCKT 13
- TOI 0
- Target Price
- RCKT $18.50
- TOI N/A
- AVG Volume (30 Days)
- RCKT 4.7M
- TOI 2.2M
- Earning Date
- RCKT 08-04-2025
- TOI 08-12-2025
- Dividend Yield
- RCKT N/A
- TOI N/A
- EPS Growth
- RCKT N/A
- TOI N/A
- EPS
- RCKT N/A
- TOI N/A
- Revenue
- RCKT N/A
- TOI $403,152,000.00
- Revenue This Year
- RCKT N/A
- TOI $23.95
- Revenue Next Year
- RCKT N/A
- TOI N/A
- P/E Ratio
- RCKT N/A
- TOI N/A
- Revenue Growth
- RCKT N/A
- TOI 17.64
- 52 Week Low
- RCKT $2.19
- TOI $0.13
- 52 Week High
- RCKT $26.98
- TOI $3.50
- Technical
- Relative Strength Index (RSI)
- RCKT 31.96
- TOI 39.47
- Support Level
- RCKT $2.50
- TOI $2.09
- Resistance Level
- RCKT $2.70
- TOI $2.87
- Average True Range (ATR)
- RCKT 0.20
- TOI 0.21
- MACD
- RCKT 0.11
- TOI -0.07
- Stochastic Oscillator
- RCKT 4.82
- TOI 18.29
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.